From Our Thought Leader's

Breaking Barriers in CAR T Cell Therapy: Martin Westberg on How the Sefia Platform is Transforming Manufacturing

In this insightful interview with Martin Westberg, Vice President and General Manager of Cell Therapy at Cytiva, BioPharma BoardRoom delve into the transformative advancements brought by the Sefia platform. Martin discusses how this innovative t... Read more

06 June, 2024 | Thursday | Interview
Merck CEO Belén Garijo Forecasts Organic Growth Recovery in 2024 Amid Solid First Quarter Performance

Financial results of Q1 2024 Healthcare with strong performance Electronics increases sales and earnings organically, driven by higher demand for semiconductor materials Inventory destocking in Life Science continues; sales recovery expected in ... Read more

15 May, 2024 | Wednesday | Company results
Charles River's CEO, James C. Foster, Optimistic About Growth Amidst First-Quarter Performance

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023. The impact of foreig... Read more

13 May, 2024 | Monday | Company results
Bio-Rad's CEO, Norman Schwartz, Finds Hope in Adversity: "Our Vision Remains Strong Despite Market Challenges"

  First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compared to $676.8 million reported for the first quarter of 2023. On a currency-neutral basis, quarterly sales decreased 9.6 percent compared to the same perio... Read more

08 May, 2024 | Wednesday | Company results

Bio Finance

Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence Therapeutics to Eli Lilly and Company. Seed round led by Pontifax and includes top-tier life sc... Read more

11 June, 2024 | Tuesday | News
Asensus Surgical to be Acquired by KARL STORZ in $300 Million Deal

Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. ("KARL S... Read more

10 June, 2024 | Monday | News

Contract Services

Sharp Announces Expansion of Macungie Facility to Meet Surging Demand for Sterile Injectable Packaging

  Sharp, a global leader in contract packaging, clinical supply services and small-scale sterile manufacturing, has  announced plans for the expansion of its Macungie, PA site in North America to increase its production capacity for steril... Read more

13 May, 2024 | Monday | News
Ribobay Pharma and Cytiva Collaborate to Revolutionize Oligonucleotide Manufacturing

    Ribobay Pharma, a prominent Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO), in conjunction with Cytiva, unveils a groundbreaking endeavor set to transform the landscape of oligonucleo... Read more

09 May, 2024 | Thursday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close